TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
248,570
|
220,201
|
193,879 |
Financial expenses |
3,006
|
1,650
|
945 |
Earnings before taxes |
19,118
|
13,776
|
10,178 |
EBITDA |
29,339
|
20,675
|
16,487 |
Total assets |
216,062
|
197,385
|
171,123 |
Current assets |
86,757
|
90,856
|
70,853 |
Current liabilities |
44,692
|
53,316
|
32,160 |
Equity capital |
117,165
|
104,102
|
95,218 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
79
|
76
![]() |
76 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
54.2%
|
52.7%
|
55.6% |
Turnover per employee |
3,146
|
2,897
|
2,551 |
Profit as a percentage of turnover |
7.7%
|
6.3%
|
5.2% |
Return on assets (ROA) |
10.2%
|
7.8%
|
6.5% |
Current ratio |
194.1%
|
170.4%
|
220.3% |
Return on equity (ROE) |
16.3%
|
13.2%
|
10.7% |
Change turnover |
28,369
|
26,322
|
28,352 |
Change turnover % |
13%
|
14%
|
17% |
Chg. No. of employees |
3
|
0
|
2 |
Chg. No. of employees % |
4%
|
0%
|
3% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.